<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">
Blogs

CU Cancer Center News and Stories

Genetics

Research    Cancer    Genetics

Research Illuminates a Therapeutic Strategy to Induce Cancer Cell Death

Cancer is a disease driven by gene mutations. These mutated genes in cancer fall into two major categories: tumor suppressors and oncogenes. Mutations in tumor suppressor genes can allow tumors to grow unchecked – a case of no brakes – while mutations in oncogenes can activate cell proliferation, pushing the gas pedal all the way to the floor.


Author Rachel Sauer | Publish Date February 10, 2023
Full Story

Patient Care    Ovarian Cancer    Immunotherapy    Genetics

Innovative Immunotherapy Treatment Helps Ovarian Cancer Patient See Amazing Results

People often tell Winona Williams that she’s brave, and she is. Ovarian cancer could easily become a dark cloud over her, shadowing every minute of every day.


Author Rachel Sauer | Publish Date September 20, 2022
Full Story

Genetics   

New Co-Director of Hereditary Cancers Focused on Improving Access to Genetic Counseling and Testing

As genetic counseling and genetic testing continue gaining importance in the world of cancer, the new co-director of hereditary cancers in the University of Colorado Cancer Center is aiming to increase awareness of these important resources for patients.


Author Rachel Sauer | Publish Date September 06, 2022
Full Story

Research    Breast Cancer    Genetics

Commonly Mutated Gene Shown to Drive Therapeutic Resistance in HER2-Positive Breast Cancer

PIK3CA is a gene that makes an enzyme called PI3K, which is involved in many important cell functions. When PIK3CA mutates, however, it can make the PI3K enzyme become overactive and cause cancer cells to grow.


Author Rachel Sauer | Publish Date June 22, 2022
Full Story

Research    Cancer    Genetics

Drug Developed in CU Lab Shows Promise Against a Novel Oncogene that Supports Cancer Progression

An enzyme that has been identified as instrumental in the progression of many types of cancer is meeting its match in inhibitors synthesized and evaluated by University of Colorado (CU) Cancer Center researchers.


Author Rachel Sauer | Publish Date April 04, 2022
Full Story

Diversity    Cancer    Genetics

The genetic diversity that may explain differences in cancer rates across ethnicities

Paul Norman, PhD, was born in the Midlands region of Central England in the county town of Shrewsbury, which, coincidentally, is also the birthplace of the naturalist and explorer, Charles Darwin. And like Darwin, Norman set out on a mission to categorize the diversity of life. Only, while Darwin concerned himself with things he could see – the beak shape of Galapagos finches, for example – Norman explores the diversity of cells hidden inside our bodies. Even more specifically, Norman, who recently joined University of Colorado Cancer Center as a mentored member, researches the diversity of tiny proteins that sit on the surface cancer cells. What seems little could be very big: Differences in these proteins across ethnicities could help to explain the differences in cancer rates between human cultures. 


Author Cancer Center | Publish Date May 13, 2019
Full Story

CU Cancer Center In the News

Gripped

Climber Achieves Impressive V15 Just 18 Months After Leukemia Diagnosis

news outletGripped
Publish DateMarch 27, 2024

Just 18 months after his leukemia diagnosis and on the brink of a bone marrow transplant, Chen defied the odds with an inspiring ascent. Reflecting on his journey, Chen's resilience shines through as he remains optimistic and determined for the future.

Full Story
EurekAlert

Sensory Nerves Appear to Drive Head and Neck Cancer Growth

news outletEurekAlert
Publish DateMarch 06, 2024

Researchers at the University of Colorado Anschutz Medical Campus found that drugs like botox may slow head and neck cancer progression by targeting nerve interactions in tumor environments, impacting immune responses. This study could lead to new treatments for patients intolerant to traditional therapies.

Full Story
Mile High Magazine

Mile High Magazine - March is Colorectal Awareness Month

news outletMile High Magazine
Publish DateFebruary 25, 2024

Christopher Lieu, MD speaks on March being Colorectal Cancer Awareness Month and the importance of screening.

Full Story
National Institutes of Health (NIH)

NIH research network to evaluate emerging cancer screening technologies

news outletNational Institutes of Health (NIH)
Publish DateFebruary 21, 2024

In 2024, the network will launch a pilot study, known as the Vanguard Study on Multi-Cancer Detection, to address the feasibility of using multi-cancer detection (MCD) tests in future randomized controlled trials.

Full Story